• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Interpreting genetic variants in kidney and genitourinary disorders will likely require systematic curation of clinical variant databases

byCaitlyn HuiandDeepti Shroff
December 3, 2018
in Chronic Disease, Nephrology, Preclinical, Public Health, Urology
Reading Time: 2 mins read
Non-invasive prenatal testing linked to decreased diagnostic testing
Share on FacebookShare on Twitter

1. This secondary analysis of genetic data emphasized the high number of potentially “pathogenic” variants that are revealed through exome sequencing when analyzing a large cohort of self-reported healthy adults.

2. The authors of this study concluded that with exome sequencing becoming a more frequently used tool in clinical diagnostics, it will be critical to ensure systematic curation of clinical variant databases across medical subspecialties and large, longitudinal studies.

Evidence Rating Level: 2 (Good)

Study Rundown: Exome sequencing is an increasingly used clinical tool for diagnostics. Large-scale analysis of different traits and populations through exome sequencing is poised as a potential key tool to improved diagnoses of genetic conditions and understanding genetic variants leading to disorders. The authors of this study aimed to examine the burden of candidate pathogenic varients that have emerged from exome sequencing, with respect to kidney and genitourinary disorders. Generally, they observed that strict monitoring of exome reporting related to kidney and genitourinary disorders would be important to avoid unnecessary referrals to geneticists and misclassification of conditions. The main limitation of this study was that there was restricted access to health record data; consequently, the authors could not extract all variables necessary for a thorough assessment of phenotypic agreement compared to the genetic diagnoses through exome sequencing. Furthermore, the authors acknowledged that some information was incomplete regarding age at recruitment.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Whole genome sequencing in the clinic: empowerment or too much information?

RELATED REPORTS

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

Most routine blood tests do not require prolonged fasting

Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases

In-Depth [retrospective cohort]: The authors of this study conducted a secondary analysis to evaluate the exome data of a cohort of self-identified healthy adults that consented for their anonymous sequence data to be available for genetic studies. The authors specifically looked at kidney and genitourinary disorders, generating a list of 625 genes associated with Mendelian forms of these conditions. They found that 23.3% of all of the participants carried a potential pathogenic variant for a kidney or genitourinary disorder. Then, the authors applied a strict filtering analysis based on allele frequency. This process resulted in 1.4% of the cohort that continued to be classified with a candidate pathogenic variant – a number that is still above currently reported genetic kidney and genitourinary conditions. One of the main conclusions drawn from this study was acknowledging the challenges of interpreting genetic variants when analyzing large volumes of exome data. Further, they stated that these genetic sequencing analyses would benefit from longitudinal studies with clinical follow-up to determine the pathogenicity of rare variants identified through exome sequencing. 

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder

Next Post

2 Minute Medicine Rewind December 4, 2018

RelatedReports

Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
2 Minute Medicine

Most routine blood tests do not require prolonged fasting

October 9, 2026
Artificial Intelligence

Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases

October 9, 2026
Chronic Disease

Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis

October 8, 2026
Next Post
Intensive rehabilitation not superior to traditional therapy for arm function after stroke

2 Minute Medicine Rewind December 4, 2018

Oral probiotics during pregnancy not linked to preterm delivery

Quick Take: Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis

Physician visual assessment of coronary stenosis severity overestimates quantitative coronary angiography

The CorMicA Trial: Medical therapy guided by invasive coronary function testing offers symptomatic improvement of angina for patients with nonobstructive coronary artery disease

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.